FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets

28,490 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 6800 - 7000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR42.16.840.1.113883.3.526.3.1471Other Disorders of Optic Nerveactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1473Other Endophthalmitisactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1475Prior Penetrating Keratoplastyactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1477Purulent Endophthalmitisactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1478Retinal Detachment with Retinal Defectactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1479Retinal Vascular Occlusionactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1480Other Proliferative Retinopathyactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1482Separation of Retinal Layersactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1483Visual Acuity 20/40 or Betteractive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1491Major Depressive Disorder Activeactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1492Psych Visit Diagnostic Evaluationactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1496Psych Visit Psychotherapyactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1530Speech and Hearing Evaluationactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1558Morgagnian Cataractactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1559Macular Scar of Posterior Polaractive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1560Best Corrected Visual Acuity Exam Using Snellen Chartactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1561Medications for Above Normal BMIactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1562Medications for Below Normal BMIactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1563Underweightactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1566Adult Depression Medicationsactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1567Adolescent Depression Medicationsactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1568Follow Up for Adult Depressionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1569Follow Up for Adolescent Depressionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1570Referral for Adolescent Depressionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1571Referral for Adult Depressionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1572High Intensity Statin Therapyactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1573LDL Cholesterolactive2025-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1574Low Intensity Statin Therapyactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1575Moderate Intensity Statin Therapyactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1576Outpatient Encounters for Preventive Careactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1578Follow Up Within 4 Weeksactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1580Referral to Primary Care or Alternate Provideractive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1581Lifestyle Recommendationactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1582Patient Declinedactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1583Referral or Counseling for Alcohol Consumptionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1584Hospice Care Ambulatoryactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.3000Metforminactive2019-12ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.319Prostate Canceractive2020-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.320Bone Scanactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.326Primary Open Angle Glaucomaactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.327Diabetic Retinopathyactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.353End Stage Renal Diseaseactive2020-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.362Asthmaactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.366Arrhythmiaactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.367Atrioventricular Blockactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.368Cardiac Pacer in Situactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.369Coronary Artery Disease No MIactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.370Hypotensionactive2020-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.371Cardiac Surgeryactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.376Heart Failureactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.378Pregnancyactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.398Prostate Cancer Treatmentactive2025-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.399Salvage Therapyactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.401Prostate Specific Antigen Testactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.403Initial Myocardial Infarctionactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.412Bradycardiaactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.451Pain Warranting Further Investigation for Prostate Canceractive2020-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.471Bilateral Oophorectomyactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.485Chemotherapyactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.509Tobacco Use Cessation Counselingactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.600.1.1498Medications for Above Normal BMIactive2025-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.600.1.1499Medications for Below Normal BMIactive2022-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.600.1.1519Follow Up for Above Normal BMIactive2017-05ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.600.1.1523Follow Up for Above Normal BMIactive2017-08ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.600.1.1524Follow Up for BMI Outside Normal Parametersactive2024-02ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.600.1.1525Follow Up for Above Normal BMIactive2025-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.600.1.1526Follow Up for Above Normal BMIactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.1.1527Referrals Where Weight Assessment May Occuractive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.600.1.1528Follow Up for Below Normal BMIactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.600.1.1549Follow Up for Below Normal BMIactive2023-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.600.1.1550Follow Up for Below Normal BMIactive2023-02ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.600.1.1551Follow Up for Below Normal BMIactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.1.1578Palliative Careactive2021-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.1.1579Palliative or Hospice Careactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.600.1.1608Encounter to Document Medicationsactive2025-01ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.600.1.1609Encounter to Document Medicationsactive2025-02ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.600.1.1610Referrals Where Weight Assessment May Occuractive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.1.1751Encounter to Evaluate BMIactive2024-09ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.600.1.1834Encounter to Document Medicationsactive2024-09ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.600.1.1917Encounter to Document Medicationsactive2021-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.1.695Encounter to Evaluate BMIactive2025-02ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.600.1.885Encounter to Evaluate BMIactive2018-03ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.600.1.886Encounter to Evaluate BMIactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.1475Referral to Primary Care or Alternate Provideractive2021-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.1476Pharmacologic Therapy for Hypertensionactive2025-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.600.1482Laboratory Tests for Hypertensionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.600.1497Encounter to Screen for Blood Pressureactive2024-02ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.600.1508Lifestyle Recommendationactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.1509Weight Reduction Recommendedactive2022-02ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.600.1510Weight Reduction Recommendedactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.600.1511Dietary Recommendationsactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.1512Dietary Recommendationsactive2025-01ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.600.1514Dietary Recommendationsactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.600.1515Dietary Recommendationsactive2025-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.600.1516Exercise Classactive2017-05ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.600.1518Recommendation to Increase Physical Activityactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.600.1537Follow Up Within 4 Weeksactive2017-05ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.1538Encounter to Screen for Depressionactive2025-02ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.600.1914Encounter to Screen for Depressionactive2020-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.1915Encounter to Screen for Depressionactive2023-02ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.600.1916Encounter to Screen for Depressionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.600.1918Encounter to Screen for Blood Pressureactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.192Encounter to Screen for Blood Pressureactive2025-02ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.600.1920Encounter to Screen for Blood Pressureactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.600.2387Overweight or Obeseactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.2388Underweightactive2022-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.2395Finding of Hypertensionactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.2462Laboratory Tests for Hypertensionactive2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.600.2466Dental Tooth Extractionactive2022-02ushl7
us.nlm.vsacR42.16.840.1.113883.3.600.259Diagnosis of Hypertensionactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.261Diagnosis of Hypertensionactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.600.263Diagnosis of Hypertensionactive2024-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.600.467Follow Up for Adolescent Depressionactive2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.468Follow Up for Adult Depressionactive2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.469Adolescent Depression Medicationsactive2023-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.600.470Adult Depression Medicationsactive2024-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.600.537Referral for Adolescent Depressionactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.538Referral for Adult Depressionactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.791Patient Declinedactive2025-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.805Weight Reduction Recommendedactive2022-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.810Recommendation to Increase Physical Activityactive2017-05ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.600.823Referral or Counseling for Alcohol Consumptionactive2022-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.6366.117Absence of Cervixactive2024-08ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.666.5.1743General or Neuraxial Anesthesiaactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.666.5.1940Immunocompromised Conditionsactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.666.5.2262CABG Surgeriesactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.666.5.2328Immunocompromised Conditions I10active2022-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.666.5.2343Immunocompromised Conditionsactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.666.5.3011Acute Myocardial Infarctionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.666.5.3024Acute Myocardial Infarctionactive2016-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.666.5.307Encounter Inpatientactive2020-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.666.5.335Bone Marrow Transplantactive2021-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.666.5.336Bone Marrow Transplantactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.666.5.404Bone Marrow Transplantactive2024-02ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.666.5.623Acute Myocardial Infarctionactive2024-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.666.5.694CABG Surgeriesactive2024-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.666.5.737PCIactive2018-08ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.666.5.747Endotracheal Intubationactive2017-05ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.128Bipolar Disorderactive2024-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.246Personality Disorder Emotionally Labileactive2024-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.247Personality Disorder Emotionally Labileactive2022-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.248Personality Disorder Emotionally Labileactive2022-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.249Personality Disorder Emotionally Labileactive2023-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.254Dysthymiaactive2022-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.256Dysthymiaactive2022-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.257Dysthymiaactive2023-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.262Deceasedactive2014-05ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.263PHQ 9 and PHQ 9M Toolsactive2022-02ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.269Hepatitis Bactive2017-08ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.271Hepatitis Bactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.272Hepatitis Bactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.43Bipolar Disorderactive2022-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.44Bipolar Disorderactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.1.45Bipolar Disorderactive2022-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.11.721Deceasedactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.67.1.101.11.723PHQ-9 Toolactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.6929.2.1000Estimated Glomerular Filtration Rateactive2024-02ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.6929.2.1002Urine Albumin Creatinine Ratioactive2025-03ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.6929.3.1000Estimated Glomerular Filtration Rateactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.6929.3.1007Urine Albumin Creatinine Ratioactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1000Strabismic Amblyopiaactive2019-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1001Strabismic Amblyopiaactive2019-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1002Refractive Amblyopiaactive2019-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1003Refractive Amblyopiaactive2019-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1004Routine Ophthalmological Examinationactive2019-09ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1005Pediatric Best Corrected Visual Acuity Examactive2019-09ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1006LogMAR Visual Acuity Examactive2019-09ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1007Aphakiaactive2019-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1008Aphakiaactive2019-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1009Infantile and Juvenile Cataractactive2019-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1010Infantile and Juvenile Cataractactive2019-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1011Congenital Corneal or Anterior Segment Conditionsactive2019-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1012Congenital Corneal or Anterior Segment Conditionsactive2019-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1013Eyelid or Orbital Conditionsactive2019-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1014Eyelid or Orbital Conditionsactive2019-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1015Coloboma of Optic Discactive2019-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1016Coloboma of Optic Discactive2019-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1017Hemorrhage of Optic Nerve Sheathactive2019-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1018Hemorrhage of Optic Nerve Sheathactive2019-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1019Optic Nerve Hypoplasiaactive2019-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1020Optic Nerve Hypoplasiaactive2019-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1021Disorder of Visual Cortex Due to Underlying Conditionactive2019-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1022Disorder of Visual Cortex Due to Underlying Conditionactive2019-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1023Cortical Blindnessactive2019-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1024Cortical Blindnessactive2019-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1025Congenital Condition of Retinaactive2019-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.8420.2.1026Congenital Condition of Retinaactive2019-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.8420.3.1000Strabismic Amblyopiaactive2019-09ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.8420.3.1001Refractive Amblyopiaactive2019-09ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.8420.3.1002Routine Ophthalmological Examinationactive2019-09ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.8420.3.1003Pediatric Best Corrected Visual Acuity Examactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.8420.3.1004LogMAR Visual Acuity Examactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.8420.3.1005Aphakiaactive2019-09ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.8420.3.1006Infantile and Juvenile Cataractactive2019-09ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.8420.3.1007Congenital Corneal or Anterior Segment Conditionsactive2019-09ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.8420.3.1008Eyelid or Orbital Conditionsactive2019-09ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.8420.3.1009Coloboma of Optic Discactive2019-09ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.8420.3.1010Hemorrhage of Optic Nerve Sheathactive2019-09ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.8420.3.1011Optic Nerve Hypoplasiaactive2019-09ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.8420.3.1012Disorder of Visual Cortex Due to Underlying Conditionactive2019-09ushl7vsac